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Microvascular free tissue transfer, a reliable technique for head and neck 
reconstruction, was introduced in 1959.1 Success rates of 90–99% have consistently 
been reported.2 Complications can be divided into three main groups: general 
condition related, recipient area related, and procedural related. Currently there is no 
consensus concerning antithrombotic agents, antibiotics, or monitoring techniques. 
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Therefore the aim of the current study was to review current literature dealing 
with microvascular free-tissue transfer and factors influencing the outcome. 
 
Antiobiotics in Microsurgery 
The intraoral mucosa is exposed to oropharyngeal secretion, saliva, and 
bacteria and only a very few studies are available that discuss antibiotics and wound 
infections following a free-flap transfer. Wound infection rates between 26 and 48% 
have been reported for reconstruction in the aero-digestive tract under prophylactic 
antiobotics.3,4 The incidence of infections in clean-contaminated head and neck 
cancer surgery without preoperative antibiotics has been reported at 30-80%.5 But in 
the pretreated mucosa (e.g., with radiation or chemotherapy) the immune defense 
seems to be reduced. Penel et al.3 described five significant variables for wound 
infection: tumor stage, previous chemotherapy, duration of preoperative hospital stay, 
permanent tracheotomy, and presence of hypopharyngeal and laryngeal cancers. On 
the other hand, Cloke et al.6 studied 100 patients on a standard antibiotic protocol 
and found in 21 patients a wound infection without statistically significant association 
between infected wound complications and a history of smoking, pre-operative 
radiotherapy or chemotherapy. Ogihara et al.7 reported that age, sex, body mass 
index, history of alcohol, and diabetes as not significantly associated with wound 
infections.  
Concerning the length of antibiotic ingestion, short-term (24-48 hours) seems to 
be as efficient as long-term. Carroll et al.8 studied 74 patients to whom were given 
either 3 or 15 doses of clindamycin after free-flap reconstruction of the head and 
neck; there were no significant differences in the wound infections. Tumor size was 
reported as an important factor.9 One reason could be the reduced nutrition in 
patients with large tumors. 
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Several others have been discussed as possible influencing factors, for 
example, tooth extraction seems to be no risk factor.3 Also, node status seems to 
play no role.3 The influence of preoperative mouth wash was not mentioned. 
Concerning surgical procedures in uncontaminated fields, like parotidectomy or 
excision of the submandibular gland, antibiotics seem to have no influence.10 To 
prevent postoperative infections, dead space formation should be avoided through 
use of drainage tubes of a larger diameter, and they should be squeezed regularly. 
Furthermore, antibiotics should be used every 6 hours in prolonged operations.7 
In our hands a standardized antibiotic regime with a combination of amoxicillin 2 
g and clavulanate potassium 0.2 g i.v. for 5 days is sufficient in most cases. 
 
Postoperative Anticoagulation 
Failures can result from microvascular thrombosis. Therefore, the question 
arises whether anticoagulation might lead to a decreased failure rate. The risk for 
thrombosis seems to be highest during the first 2 postoperative days.11,12 For 
prevention, several agents have been used, like heparin, acetylsalicylic acid, dextran, 
and prostaglandin E1. There seems to be no significant difference with bleeding, 
thromboembolism, and free-flap loss with either aspirin 325mg/d or low-dose heparin 
(5000 IE/d).13 Prostaglandin E1 significantly prolongs the time of stasis in the 
arterioles14, but not many studies have been performed. The main site of thrombosis 
is the venous side because of slower blood flow.11,15 Several studies have reported 
on the use of dextran. For example, Disa et al.16 reported a 7.2 times greater rate of 
developing a systemic complication when compared with patients receiving 
acetylsalicylic acid.  
Side effects, other than the bleeding risk of anticoagulation should not be 
underestimated. Aspirin can cause gastric ulceration and nephrotoxicity. Heparin can 
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cause a heparin-induced thrombocytopenia. Dextran is known for anaphylaxis, 
pulmonary and cerebral edema, and platelet dysfunction. 
To achieve statistical relevance, a high number of flaps by the same surgeon 
would have to be performed. To date, there has been no generally accepted 
agreement on the ideal agent or its administration. The benefit of using aspirin or 
heparin remains, therefore, theoretically based on related studies in cerebrovascular 
and cardiovascular diseases. Antithrombotic agents do not substitute for 
microsurgical techniques. In cases of small vessels, significant size mismatch, vein 
graft, or a vessel of poor quality, one can consider prophylactic antithrombotics.17 
 
Recipient Vessel 
Anastomosis to the external jugular (EJ) vein showed a significantly higher 
failure rate than that to the internal jugular (IJ) system. Compared to the IJ system, 
the EJ vein shows a relatively low flow and small caliber.18 The IJ vein has a negative 
pressure with respiration, larger caliber, and the enabling of end-to-side 
anastomosis.19 Chalina et al. 18 compared the EJ vein and the IJ system. Venous 
thrombosis occurred only in the anastomoses to the EJ vein. In general, the causes 
of venous thrombosis can be classified according to Virchow`s classic triad: (1) 
endothelium damage, (2) stasis, and (3) hypercoagulated state. In line with this triad 
Brown et al.20 confirmed the main surgical requirements when dealing with 
anastomoses: (1) atraumatic manipulation of the vein, (2) avoiding thermal injury with 
electrocoagulation, (3) avoiding desiccation of the vessel once it is denuded of 
adventitia, and (4) attention to the ligation of the jugular side branches for 
maintenance of optimal flow characteristics. 
Some authors advocate end-to-end anastomosis because of laminar flow, but 
others have reported that end-to-side anastomosis does not increase the incidence 
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of anastomotic failure. Advantages of end-to-side anastomosis are the possibility of 
multiple anastomoses to a single vessel, overcoming discrepancies in vessel sites, 
and no vessel retraction. Most studies seem to show no difference in the outcome 
with a vein graft.21 But, Khouri at al.22 reported in 493 free flaps that the need for vein 
grafts had raised the odds of intraoperative thrombosis by the factor of 5 and the 
odds of need of reexploration due to postoperative thrombosis by the factor of 2.9. 
For defects in the upper third of the face Yazar23 recommends the ipsilateral 
superfacial temporal vessels as first choice and the facial vessels as second choice. 
For superficial middle third defects of the face he suggests the facial vessels (first 
choice) and superior thyroid vessels (second choice). For complex defects in this 
area facial vessels or superficial temporal vessels are recommended. For lower third 
defects ipsilateral facial vessel (first choice) and ipsilateral superior thyroid vessels 
(second choice) are advocated. If a contralateral vessel is needed the facial vessels 
are recommended (see Fig. 1). But in cases of cancer, the distance to possible 
metastases or tumor should be taken into account in order to avoid vessel spasms. 
 
Preirradiated Graft Bed 
Most studies confirm that prior radiotherapy does not adversely affect flap 
survival.24 But in some studies perivascular fibrosis and endothelial damage have 
been described.25,26 Russell et al.27 showed that radiation induced intima thickening, 
proteoglycan deposition, and inflammatory cell infiltration. Schultze-Mosgau et al.26 
reported a reduced clinical success rate (84%) of free vascular graft in patients with 
previous radiotherapy of 60-70 Gy. Furthermore, if the time between previous 
radiotherapy and the free-flap surgery was prolonged — that is, 1 to 7 years — a 
significantly reduced and more irregular capillary distribution occurred. 
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Coupling Device 
Anastomotic-coupling devices offer an alternative to traditional hand-sewn 
anastomosis. They are commonly accepted in venous anastomoses, but their use in 
arterial anastomoses remains limited. Yap et al.28 reported no statistically significant 
difference between the two techniques. Chernichenko et al.29 reported a failure rate 
of 1% in 134 patients with end-to-side venous anastomosis with a coupling device. 
Fewer studies are available concerning arterial coupling. Ross et al.30 studied 
50 coupled arterial anastomoses with complications in 2 vessels. Shindo et al.31 
mentioned two thromboses in 16 arterial anastomoses while Ahn et al.32 reported 5 in 
29. One problem arises in increased thickness and decreased pliability of the arterial 
vessel walls, especially in arterial diameters of less than 2.5mm.30 
 
Salvage Treatment 
Thrombosis in the venous part seems to be more common and survival rate for 
venous thrombosis seems to be higher. Nakatsuka et al.33 reported 15% flap survival 
in cases of arterial thrombosis, despite thrombectomy. But removal of venous 
thrombus leads to a survival rate of 60%. In a study of 113 flaps re-explored because 
of compromise, Chen et al.34 was able to show that the time the flap compromise 
occurs is the significant predictor of flap salvage outcome; the salvage rate (complete 
salvage and partial salvage) was between 80 and 100% (94 of 110) when the fist 
circulatory compromise occurred during the first to fifth 24-hour period after sugery. 
Panchapakesan et al.15 recommended the use of thrombolysis (streptokinase or 
urokinase) in cases where surgical thrombectomy failed. Lipton and Jupiter35 were 
among the first to use streptokinase in human flap salvage. An effective dose of 
streptokinase in blood is reported to be between 1,000 and 3,000 U/ml.15 Urokinase 
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and tissue plasminogen activator are more expensive, but seem to be more effective 
in comparison to streptokinase.36 
Serletti et al.37 proposed using urokinase in cases of the more common venous 
thrombosis. Panchapakesan et al.15 showed that there are no differences between 
salvage and failure groups in regard to smoking, irradiation, or vein grafts.  
The use of hyperbaric oxygen therapy for increasing survival of flaps with 
compromised venous outflow is rarely described in the literature38,39, but not every 
unit has access to oxygen chambers, so large studies are missing. 
 
Monitoring 
The time of presentation of the flap compromise emphasizes the need for 
excellent monitoring. Most authors 11,34 advocate checking the flap color, capillary 
refill, tissue turgor, pinprick test, Doppler ultrasonography, and temperature. Baudet 
et al.40 reported in 10 free flaps that an acute 3°C drop in flap temperature is an 
indication for arterial thrombosis, whereas a 1-2°C drop is an indication for venous 
compromise. 
Hölzle et al.41 presented good results with noninvasive laser Doppler flowmetry 
and tissue spectrophotometry for detection of vascular complication in 61 patients. 
With this probe, a simultaneous noninvasive measurement of blood flow, flow 
velocity, hemoglobin concentration, and oxygen saturation is possible. Furthermore, 
Parker et al.42 were among the first to introduce the implantable Doppler. This tool is 
particularly suited to deeply placed flaps without a skin paddle monitor. It can also be 
an advantage when the anastomosis is in close proximity to great vessels, in which 
case an external Doppler can lead to wrong interpretations. 
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Overall, good postoperative monitoring and early detection of compromised flap 
perfusion leading to early interventions can result in successful salvage rates of 70% 
as Brown et al. in 2003 showed in 427 free flaps.11 
In our clinic, postoperative flap control including color, temperature, capillary 
return after streaking and Doppler signal on marked skin area is performed hourly 
during the first 24 hours and then every 4 hours for the next 2 days. We did not 
experience any incident of late detection of flap failure under this protocol. 
 
Diabetes and Microsurgery 
Different opinions are expressed in the literature. While Valentini et al.43 
reported that diabetes interferes with free-flap survival, whereas some authors do not 
support this statement.44,45 Cooley et al.45 reported that patients with diabetes are not 
at increased risk either for flap failure or for abnormal healing of the anastomoses as 
long as normal glycemia is maintained. They conclude this from their own animal 
experiment with a total of 98 syngeneic Lewis rats together with a number of cited 
clinical studies.46-49 
 
Microsurgery in Elderly Patients 
The population demographics consist of a growing proportion of elderly people, 
and age has frequently been regarded as an independent risk factor for poor surgical 
outcome. Several reasons have been mentioned: the first is heart failure, as the 
aging heart of older patients has a less efficient cardiac output under the stress of 
surgery and anesthesia,50 accompanied by lower renal blood flow, which results in 
higher sensibility for larger water and electrolyte imbalances. Second, pulmonary 
function is compromised with increased age due to smaller vital capacities and 
poorer gas exchange because of deterioration of the lung parenchyma.51 In the 
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literature no exact age seems to be associated with the word “elderly.” But surgical 
indications should not be based on age, but rather on risk assessment. Therefore, 
the American Society of Anesthesiologists (ASA) score is recommended as a tool for 
risk assessment.52 
Studies dealing with free tissue in the elderly have been done for those aged 
50,53, 60,54 65,55 and 70 years.56 The flap loss rate in these studies ranged from 1% 
out of 92 patients53 to 16.7% out of 47 patients.54 This variety indicates the difficulties 
in defining “elderly” and the expected comorbidities in older patients. 
In general, preoperative risk assessment is predictive for the development of 
postoperative morbidity.54 Serletti et al.55 analyzed 104 free flaps in patients aged 65 
and older and found surgical time longer than 10 hours as a significant factor for the 
development of postoperative surgical complications. Older patients are also less 
capable of handling large fluid shifts and significant blood loss.55 Proper fluid 
management and protein-calorie balance is therefore important. Another important 
factor in reconstructive failure seems to be the presence of peripheral vascular 
disease. 
Özkan et al.57 did not use anticoagulation. Furthermore, very reliable donor flaps 
should be used, raised by a second team in order to reduce operating time. In 
general, early postoperative mobilization, including aggressive chest physiotherapy, 
should be provided especially to elderly patients. In this group, self-induced 
postoperative mobilization is reduced compared to younger patients, and therefore 
postoperative mobilization can easily become a major concern. Jones et al.52 
reported that the average hospital stay had increased from 13.5 days to 24 days 
because of pulmonary problems and alcohol withdrawal. This finding highlights the 
need for good risk assessment and postoperative early mobilization, including chest 
physiotherapy. 
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Conclusion 
The summarized factors as presented in Table 1 lead to some conclusions one 
should consider. 
In addition to excellent microsurgical techniques, coupling devices are a 
promising new technique, but are not useful in all arteries. Antibiotics should be given 
in three doses, as a more lengthy dosage time seems to have no advantage. The risk 
for elderly patients can be best assessed by the ASA score, but early mobilization, 
including intense chest physiotherapy, is important. Anticoagulation can be 
considered in cases of small vessels, significant size mismatch, vein graft, or vessels 
of poor quality. Monitoring should be done hourly during the first 24 hours, and then 
every 4 hours for the next 2 postoperative days (see Fig. 2). 
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Factor group Factor grade of 
influence 
Concerned 
problem 
Relevant 
literature
Patient age and 
sex 
No influence  7 
Body mass index 
(BMI) 
No influence  7 
American Society 
of 
Anesthesiologists 
(ASA) score 
Proven 
influence 
Prolonged hospital 
stay & 
postoperative 
morbidity due to 
general 
complications 
52,54 
Diabetes mellitus controverse Infection, Failure of 
anastomoses 
7,43 
Smoking, alcohol No proven 
influence 
Healing problems 6,7,43 
Reduced 
nutrition 
Suspected but 
not proven 
influence 
Healing problems 9 
Preoperative 
hospital stay 
influence infection 3 
Tumor stage influence infection 3,9 
General 
condition 
related  
Preoperative 
chemotherapy 
controverse infection 3,6 
Preoperative 
radiotherapy 
controverse Healing problems, 
Failure of 
anastomoses 
6,24,26 
Choice of vein 
(external jugular 
vs. Internal 
jugular) 
influence Higher risk of 
thrombosis if 
external jugular 
vein is chosen 
18 
Tooth extraction No influence Infection 3 
recipient area 
related 
Lymph node 
status 
No influence infection 3 
Perioperative 
Antibiotics 
Suspected but 
not proven 
influence 
 8,10 
Handling of 
vessels during 
surgery 
Suspected but 
not proven 
influence 
Failure of 
anastomoses 
20 
Vein graft controverse  21,22 
Choice of 
technique 
No influence E.g. thrombosis 19 
Coupling device 
(vein) 
No influence Failure of 
anastomoses 
28,29 
procedural 
related 
Coupling device 
(arteria) 
Suspected but 
not proven 
influence 
Failure of 
anastomoses 
30-32 
 12
Surgical time Proven for 
over 10 hours 
Postoperative 
morbidity 
55 
Hyperbaric 
oxygenation 
Suspected but 
not proven 
influence 
 38,39 
postoperative 
anticoagulation 
controverse Postoperative 
thrombosis 
13,22 
Flap monitoring Influence Early salvage 11 
 
Table 1: Main factors influencing survival of free-flap 
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1. superficial temporal vessels
Upper third
2. facial vessels
1. facial vessels
superficial part
2. superior thyreoid vessels
Middle third
facial vessels
complex defects
superficial temporal vessels
1. facial vessels
ipsilateral
Lower third 2. superior thyreoid vessels
contralateral facial vessels
 
 
Fig. 1: choice of vessels according to Yazar23 
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PREOPERATIVE
• ASA score assessment
• Allen`s test
• Possible angio-MRI
INTRAOPERATIVE
• If possible ansatomosis to the IJ system
• Attention to the ligation of the jugular side branches for maintenance of otpimal flow
• Every 6 hours antibiotics in prolonged operations
POSTOPERATIVE
• Antibiotics in together three doses
• Early mobilization, chest physiotherapy
• Monitoring hourly during the first 24 hours and thenevery 4 hours for the next 2 postoperative 
days
• Anticoagulation in cases of small vessels, significant size match, vein graft, vessels of poor
quality
• Thrombolysis (streptokinase or urokinase) in cases where surgical thrombectomy failed
 
 
Fig. 2: Overview of recommendations 
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